MedTrace Logo

Assessing the Effect of Staff Education on Unused Peripheral Venous Catheter Rates in Emergency Departments.

NCT07449455 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 516

Last updated 2026-03-11

No results posted yet for this study

Summary

The placement of peripheral venous catheters (PVC) is a common procedure, estimated at 25 million per year in France according to SF2H in 2005. However, this procedure exposes patients to complications (hematoma, phlebitis, edema, sepsis, hemolysis of samples), is time-consuming, and costly. There is a significant proportion of PVCs placed unnecessarily, estimated between 23.7% and 60.7% according to studies. A study conducted at the Saint-Antoine Emergency Department showed that the best indicator of non-use of PVCs is the physician's prediction of non-utilization.

The investigators expect to achieve a significant reduction in unused PVCs after the intervention, thereby reducing adverse effects associated with PVC placement, freeing up paramedical time, and having a positive ecological and economic impact.

Conditions

  • Peripheral Venous Catheter

Interventions

OTHER

Medical staff educational intervention

The staff training aims to enforce prescription recommendations in patient care and will involve multiple informational meetings with medical and paramedical teams, sending emails, and posting posters in various emergency care stations. The conclusions of the literature analysis regarding the relevance of prescribing PVCs in the ED will be communicated, notably the results of the ED-cath study conducted in 2022 in the department: PVC placement exposes patients to complications (hematoma, phlebitis, edema, sepsis, hemolysis of samples), is time-consuming, and costly; it has been shown that 23.7% to 60% of PVCs placed in the ED are not used, and non-utilization of the PVC is associated with the prescriber's anticipation of non-utilization and the prescription motive "if needed."

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-22
Primary Completion
2025-01-17
Completion
2025-01-17

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07449455 on ClinicalTrials.gov